Related Experiment Video
Updated: May 13, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
[Naloxone]
Daisuke Setoguchi1, Yasuyuki Kakihana
1Department of Emergency & Intensive Care Medicine, Kagoshima University Hospital, Kagoshima 890-8520.
Abstract:
Naloxone hydrochloride is an agent capable of antagonizing respiratory depression and analgesic actions which are inherent to the opioid by competitively acting at opioid receptors. It greatly contributed to basic research on antagonistic action of opioid receptors due to its high affinity to opioid receptors, in particular, micro-receptor. Naloxone has been recommended as an analeptic agent at a guideline level for patients with revealed or suspicious opioid addiction. Further, it has also been used as a preventive and treatment agent for spinal cord ischemia. Moreover, even though it has been confirmed in 1980's that naloxone has vasopressor effect in septic shock, further clinical trials are required for its wide clinical application.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug Delivery: Enteral Route
Drugs in...
Pharmaceutical Poisoning: Treatment Strategies
Opioid Analgesics: Morphine and Other Natural Cogeners

